Llwytho...

IVIG May Be An Effective Therapy for Refractory, Active Diffuse Cutaneous Scleroderma

OBJECTIVE: We sought to retrospectively review a single-center experience using intravenous immunoglobulin (IVIG) for the treatment of refractory, active diffuse cutaneous scleroderma. METHODS: The mean modified Rodnan skin score (mRSS) at baseline was compared to the mRSS at 6, 12, 18 and 24 months...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Rheumatol
Prif Awduron: Poelman, Corrie L., Hummers, Laura K., Wigley, Fredrick M., Anderson, Cynthia, Boin, Francesco, Shah, Ami A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4314512/
https://ncbi.nlm.nih.gov/pubmed/25433527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.140833
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!